Intranasal and subcutaneous administration of dopamine D3 receptor agonists functionally restores nigrostriatal dopamine in MPTP-treated mice.
about
Lipopolyplex for Therapeutic Gene Delivery and Its Application for the Treatment of Parkinson's DiseaseGene-based therapies in Parkinson's disease.Advances and challenges in the search for D2 and D3 dopamine receptor-selective compounds.Impact of Plant-Derived Flavonoids on Neurodegenerative Diseases.Occupancy of pramipexole (Sifrol) at cerebral dopamine D2/3 receptors in Parkinson's disease patientsNeurotoxin mechanisms and processes relevant to Parkinson's disease: an update.
P2860
Intranasal and subcutaneous administration of dopamine D3 receptor agonists functionally restores nigrostriatal dopamine in MPTP-treated mice.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Intranasal and subcutaneous ad ...... dopamine in MPTP-treated mice.
@en
Intranasal and subcutaneous ad ...... dopamine in MPTP-treated mice.
@nl
type
label
Intranasal and subcutaneous ad ...... dopamine in MPTP-treated mice.
@en
Intranasal and subcutaneous ad ...... dopamine in MPTP-treated mice.
@nl
prefLabel
Intranasal and subcutaneous ad ...... dopamine in MPTP-treated mice.
@en
Intranasal and subcutaneous ad ...... dopamine in MPTP-treated mice.
@nl
P2093
P2860
P1476
Intranasal and subcutaneous ad ...... dopamine in MPTP-treated mice.
@en
P2093
Chu Lan Lao
Yen-Hsi Kuo
Yueh-Ting Hsieh
P2860
P2888
P304
P356
10.1007/S12640-013-9408-1
P577
2013-07-03T00:00:00Z